DK2202307T3 - Fremgangsmåde til fremstiling af et antistof - Google Patents

Fremgangsmåde til fremstiling af et antistof

Info

Publication number
DK2202307T3
DK2202307T3 DK08838661.0T DK08838661T DK2202307T3 DK 2202307 T3 DK2202307 T3 DK 2202307T3 DK 08838661 T DK08838661 T DK 08838661T DK 2202307 T3 DK2202307 T3 DK 2202307T3
Authority
DK
Denmark
Prior art keywords
antibody
producing
Prior art date
Application number
DK08838661.0T
Other languages
English (en)
Other versions
DK2202307T4 (da
Inventor
Yoshiki Yamada
Tatsuya Kiyasu
Kazuyuki Tabata
Akihiro Kuzumaki
Mai Yamashiro
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40567372&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2202307(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK2202307T3 publication Critical patent/DK2202307T3/da
Publication of DK2202307T4 publication Critical patent/DK2202307T4/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
DK08838661.0T 2007-10-15 2008-10-14 Fremgangsmåde til fremstiling af et antistof DK2202307T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007267384 2007-10-15
JP2008103308 2008-04-11
PCT/JP2008/068588 WO2009051108A1 (ja) 2007-10-15 2008-10-14 抗体の製造方法

Publications (2)

Publication Number Publication Date
DK2202307T3 true DK2202307T3 (da) 2014-09-15
DK2202307T4 DK2202307T4 (da) 2021-10-04

Family

ID=40567372

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08838661.0T DK2202307T4 (da) 2007-10-15 2008-10-14 Fremgangsmåde til fremstiling af et antistof

Country Status (17)

Country Link
US (3) US9683027B2 (da)
EP (1) EP2202307B2 (da)
JP (4) JP4976502B2 (da)
KR (1) KR101558009B1 (da)
CN (3) CN106244651A (da)
AU (1) AU2008312937B2 (da)
BR (1) BRPI0818674B1 (da)
CA (1) CA2701338C (da)
DK (1) DK2202307T4 (da)
ES (1) ES2499391T5 (da)
IL (2) IL205051A (da)
MX (1) MX2010004007A (da)
PL (1) PL2202307T5 (da)
SG (1) SG185302A1 (da)
SI (1) SI2202307T2 (da)
TW (1) TWI463010B (da)
WO (1) WO2009051108A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0818674B1 (pt) * 2007-10-15 2023-01-17 Chugai Seiyaku Kabushiki Kaisha Métodos para produção de um anticorpo inteiro ou de um fragmento do mesmo e para preparação de fármacos, bem como vetor recombinante
CN104928336B (zh) 2009-10-26 2020-05-08 弗·哈夫曼-拉罗切有限公司 用于生产糖基化免疫球蛋白的方法
MY163081A (en) * 2010-12-28 2017-08-15 Chugai Pharmaceutical Co Ltd Animal cell culturing method
AR095348A1 (es) * 2013-03-15 2015-10-07 Genentech Inc Medios de cultivo celular y métodos de producción de anticuerpos
BR112015032960B1 (pt) 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
US20190225694A1 (en) 2016-06-28 2019-07-25 Zaklady Farmaceutyczne Polpharma Sa Recombinant production of monoclonal antibodies
EP3541413A2 (en) 2016-11-21 2019-09-25 Polpharma Biologics S.A. Aqueous pharmaceutical formulations
WO2025134341A1 (ja) * 2023-12-22 2025-06-26 中外製薬株式会社 抗体の製造方法
WO2025141786A1 (ja) * 2023-12-27 2025-07-03 中外製薬株式会社 抗体の製造方法
WO2025232879A1 (en) 2024-05-10 2025-11-13 Cytocares (Shanghai) Inc. Anti-lilrb2 monospecific and bispecific antibody constructs and uses thereof

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JPS6459878A (en) 1987-08-31 1989-03-07 Matsushita Electric Industrial Co Ltd Semiconductor laser protective circuit
CA2109602C (en) 1990-07-10 2002-10-01 Gregory P. Winter Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
AU8507191A (en) 1990-08-29 1992-03-30 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
CA2090969C (en) † 1990-09-04 2001-08-21 Russell Arthur Brierley Production of insulin-like growth factor-1 in methylotrophic yeast cells
ES2134212T3 (es) 1991-04-25 1999-10-01 Chugai Pharmaceutical Co Ltd Anticuerpo humano reconstituido contra el receptor de la interleuquina 6 humano.
EP0605522B1 (en) 1991-09-23 1999-06-23 Medical Research Council Methods for the production of humanized antibodies
PT1696031E (pt) 1991-12-02 2010-06-25 Medical Res Council Produção de auto-anticorpos a partir de reportórios de segmentos de anticorpo e exibidos em fagos
AU3328493A (en) 1991-12-17 1993-07-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
JP3507073B2 (ja) 1992-03-24 2004-03-15 ケンブリッジ アンティボディー テクノロジー リミティド 特異的結合対の成員の製造方法
ES2301158T3 (es) 1992-07-24 2008-06-16 Amgen Fremont Inc. Produccion de anticuerpos xenogenicos.
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
GB9313509D0 (en) 1993-06-30 1993-08-11 Medical Res Council Chemisynthetic libraries
WO1995015388A1 (en) 1993-12-03 1995-06-08 Medical Research Council Recombinant binding proteins and peptides
US5531053A (en) 1994-06-14 1996-07-02 Hamm; Hans Spring fastener for holding insulation against an inner surface of cavity walling
CA2194907A1 (en) 1994-07-13 1996-02-01 Kouji Matsushima Reshaped human antibody against human interleukin-8
US5561053A (en) 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
EP0822830B1 (en) 1995-04-27 2008-04-02 Amgen Fremont Inc. Human anti-IL-8 antibodies, derived from immunized xenomice
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
EP0985033A4 (en) * 1997-04-04 2005-07-13 Biosite Inc POLYVALENT AND POLYCLONAL LIBRARIES
DK0979281T3 (da) 1997-05-02 2005-11-21 Genentech Inc Fremgangsmåde til fremstilling af multispecifikke antistoffer med heteromultimere og fælles bestanddele
US20020062010A1 (en) 1997-05-02 2002-05-23 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
US6171586B1 (en) * 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
AU2002307037B2 (en) † 2001-04-02 2008-08-07 Biogen Idec Inc. Recombinant antibodies coexpressed with GnTIII
US6605176B2 (en) 2001-07-13 2003-08-12 Taiwan Semiconductor Manufacturing Co., Ltd. Aperture for linear control of vacuum chamber pressure
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
DE60230918D1 (de) 2001-11-16 2009-03-05 Biogen Idec Inc Polycistronische expression von antikörpern in cho zellen
EP2204190A1 (en) 2003-07-15 2010-07-07 Chugai Seiyaku Kabushiki Kaisha IgM production by transformed cells and methods for quantifying said IgM production
AU2005222963B2 (en) * 2004-03-15 2009-10-29 Biogen Idec Ma Inc. Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
CA2544692C (en) 2004-07-09 2014-04-01 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
GB0425534D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
EP2468881A3 (en) † 2005-07-21 2012-08-15 Abbott Laboratories Multiple gene expression including sorf contructs and methods with polyproteins, pro-proteins, and proteolysis
BRPI0818674B1 (pt) * 2007-10-15 2023-01-17 Chugai Seiyaku Kabushiki Kaisha Métodos para produção de um anticorpo inteiro ou de um fragmento do mesmo e para preparação de fármacos, bem como vetor recombinante

Also Published As

Publication number Publication date
CA2701338C (en) 2018-09-18
JP6506786B2 (ja) 2019-04-24
JP2015198663A (ja) 2015-11-12
WO2009051108A1 (ja) 2009-04-23
ES2499391T5 (es) 2021-12-22
US12145978B2 (en) 2024-11-19
SG185302A1 (en) 2012-11-29
EP2202307B1 (en) 2014-08-20
AU2008312937A1 (en) 2009-04-23
EP2202307A4 (en) 2012-01-25
IL240122B (en) 2019-02-28
US11136375B2 (en) 2021-10-05
KR101558009B1 (ko) 2015-10-19
US20170275351A1 (en) 2017-09-28
ES2499391T3 (es) 2014-09-29
BRPI0818674B1 (pt) 2023-01-17
EP2202307A1 (en) 2010-06-30
JP2012143246A (ja) 2012-08-02
JP2017079794A (ja) 2017-05-18
AU2008312937B2 (en) 2015-01-22
JP5788830B2 (ja) 2015-10-07
TW200934867A (en) 2009-08-16
IL205051A0 (en) 2010-11-30
IL205051A (en) 2015-09-24
CA2701338A1 (en) 2009-04-23
JPWO2009051108A1 (ja) 2011-03-03
DK2202307T4 (da) 2021-10-04
US9683027B2 (en) 2017-06-20
SI2202307T1 (sl) 2014-11-28
CN101802192A (zh) 2010-08-11
CN106244651A (zh) 2016-12-21
MX2010004007A (es) 2010-06-15
BRPI0818674A2 (pt) 2014-10-14
US20100291627A1 (en) 2010-11-18
SI2202307T2 (sl) 2021-11-30
PL2202307T3 (pl) 2015-02-27
US20210300996A1 (en) 2021-09-30
EP2202307B2 (en) 2021-07-14
JP6092304B2 (ja) 2017-03-08
PL2202307T5 (pl) 2021-10-04
IL240122A0 (en) 2015-09-24
JP4976502B2 (ja) 2012-07-18
KR20100074184A (ko) 2010-07-01
TWI463010B (zh) 2014-12-01
CN103540632A (zh) 2014-01-29

Similar Documents

Publication Publication Date Title
DK2054711T3 (da) Fremgangsmåde til fremstilling af mikroarrays
CY2019004I1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
DK2044002T3 (da) Fremgangsmåde til fremstilling af 3-substituerede 2-amino-5-halobenzamider
DK3730045T3 (da) Fremgangsmåde til indføring af en analytsensor
DK2202307T4 (da) Fremgangsmåde til fremstiling af et antistof
DK2350128T3 (da) Fremgangsmåder til fremstilling af antistoffer fra plasmaceller
DK2451839T3 (da) Fremgangsmåde til produktion af variable domæner
BRPI0814359A2 (pt) Método
BRPI0817226A2 (pt) Método
BRPI0817726A2 (pt) Método
PL2155838T3 (pl) Sposób wytwarzania węglowodorów rozgałęzionych
DK2126801T3 (da) Fremgangsmåde til udvælgelse af information
BRPI0907532A2 (pt) Anticorpos anti-c5ar humanizados
DK1844662T3 (da) Metode til belægning af objekter
DK2531526T3 (da) Fremgangsmåde til opnåelse af antistoffer
DK2358661T3 (da) Fremgangsmåde til fremstilling af trans-4-amino-cyclohexyl-eddikesyreethylester-hcl
DK2029567T3 (da) Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
PL2155839T3 (pl) Sposób wytwarzania węglowodorów rozgałęzionych
DK3106875T3 (da) Fremgangsmåde til detektering af cancer
FI20075505L (fi) Menetelmä silmälasien valmistamiseksi
DK2061746T3 (da) Fremgangsmåde til fremstilling af diestere
DK2076330T3 (da) Fremgangsmåde til fremstilling af katalysatorer
DK2367783T3 (da) Fremgangsmåde til fremstilling af et isocyanat
DK2019118T3 (da) Fremgangsmåde til syntetisering af thymosiner
DK2160225T3 (da) Fremgangsmåde til fremstilling af krystaller